🇺🇸 Basal in United States

344 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 53 reports (15.41%)
  2. Diabetic Ketoacidosis — 46 reports (13.37%)
  3. Hypoglycaemia — 38 reports (11.05%)
  4. Foetal Exposure During Pregnancy — 37 reports (10.76%)
  5. Gestational Diabetes — 35 reports (10.17%)
  6. Blood Glucose Increased — 33 reports (9.59%)
  7. Nausea — 32 reports (9.3%)
  8. Exposure During Pregnancy — 27 reports (7.85%)
  9. Vomiting — 24 reports (6.98%)
  10. Off Label Use — 19 reports (5.52%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Basal approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Basal in United States?

University of California, San Diego is the originator. The local marketing authorisation holder may differ — check the official source linked above.